LPDX (MM)

NEW YORK, Sept. 29, 2014 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating the board of LipoScience, Inc. (NASDAQ MKT: LPDX) in connection with a buyout by Laboratory Corporation of America Holdings. Concerned LPDX investors are encouraged to contact attorney Hamilton Lindley by clicking here.

Under the terms of the proposed acquisition, LipoScience shareholders will receive approximately $5.25 per share in cash for each outstanding share of LipoScience common stock.  The law firm's investigation relates to whether the Board breached their fiduciary duty by failing to adequately shop LipoScience and if Laboratory Corporation is underpaying for LipoScience shares.

Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. LPDX stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@dunnamlaw.com with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/LPDX.

SOURCE Dunnam & Dunnam